Liver Transplant for Intrahepatic Cholangiocarcinoma.
Intrahepatic cholangiocarcinoma
Liver resection
Liver transplant
Transplant oncology
Journal
The Surgical clinics of North America
ISSN: 1558-3171
Titre abrégé: Surg Clin North Am
Pays: United States
ID NLM: 0074243
Informations de publication
Date de publication:
Feb 2024
Feb 2024
Historique:
medline:
14
11
2023
pubmed:
13
11
2023
entrez:
12
11
2023
Statut:
ppublish
Résumé
Intrahepatic cholangiocarcinoma (iCCA) tends to be asymptomatic until late stages, leading most of the patients to present at advanced stages of the disease. A combination of medical and surgical therapy is crucial for patient management. Historically, poor outcomes resulted in liver transplantation being formally contraindicated for patients with iCCA; however, recent advances in patient selection and neoadjuvant therapy have resulted in a paradigm shift in liver transplant oncology. As a result, the feasibility of liver transplantation for iCCA is being reevaluated by several centers as a therapeutic alternative for select patients with locally advanced unresectable disease.
Identifiants
pubmed: 37953037
pii: S0039-6109(23)00116-0
doi: 10.1016/j.suc.2023.07.006
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
215-225Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.